Loading...
research article
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial--VIP report no. 1
VipStudy, Group
2001
To determine if photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, GA) can improve the chance of stabilizing or improving vision (<8 letter loss) safely in patients with subfoveal choroidal neovascularization (CNV) caused by pathologic myopia.
Type
research article
Authors
VipStudy, Group
Publication date
2001
Publisher
Published in
Volume
108
Issue
5
Start page
841
End page
52
Subjects
Peer reviewed
REVIEWED
Available on Infoscience
February 16, 2011
Use this identifier to reference this record